For the most authoritative and up-to-date protocols, you can access the following resources:
Guidelines now shift away from the traditional "step-up" approach. Clinicians are encouraged to initiate advanced therapies (biologics or small molecules) earlier for moderate-to-severe cases to prevent irreversible tissue damage.
Newer agents such as IL-23 antagonists (e.g., Skyrizi) and JAK inhibitors have been integrated into the 2025 treatment algorithms. Download Nouvelles recommandations dans les MICI pdf
The latest clinical guidelines for (Maladies Inflammatoires Chroniques de l'Intestin), specifically Crohn's Disease (MC) and Ulcerative Colitis (RCH), focus on early intervention, "treat-to-target" strategies, and the integration of new-generation biological therapies like Skyrizi . Key Updates in MICI Management (2024–2026)
Offers detailed clinical practice guidelines for Crohn's Disease , including the French Recommendations for Crohn's Practice (PDF) . For the most authoritative and up-to-date protocols, you
Specific consensus documents, such as the ECCO Consensus on Dietary Management, highlight the role of diet in inducing and maintaining remission. Where to Download Official PDF Guidelines
The British Society of Gastroenterology 2025 Guidelines provide a comprehensive roadmap for both medical and surgical management. Where to Download Official PDF Guidelines The British
Recommendations explicitly limit steroid use to less than three months to avoid long-term complications.